Please login to the form below

Not currently logged in
Email:
Password:

21st Century Cures Act

This page shows the latest 21st Century Cures Act news and features for those working in and with pharma, biotech and healthcare.

Trump talks pricing and manufacturing with pharma

Trump talks pricing and manufacturing with pharma

In particular, there is concern that the orders could effectively stop the 21st Century Cures Act - one of the last actions of the Obama administration and widely welcomed by industry - in

Latest news

  • Bayer helps bankroll new stem cell company BlueRock Bayer helps bankroll new stem cell company BlueRock

    The birth of the new company also comes at an opportune time with the passage in the US of the 21st Century Cures Act, which promises to introduce a truncated registration

  • After Senate vote, Cures Act is en route to Obama for signature After Senate vote, Cures Act is en route to Obama for signature

    law. The US Senate voted 94 to 5 to approve the 21st Century Cures Act, a wide-ranging and controversial bill that will shake up the operations of the FDA and ... The Biotechnology Innovation Organization (BIO), which represents biotech companies,

  • The fifth estate The fifth estate

    Last week, Harvard's T.H. Chan School of Public Health and STAT published the results of a new poll aimed at understanding public opinion on certain provisions of the 21st ... Century Cures Act - specifically the goal of making drug and medical devices

  • Obama to nominate Dr Robert Califf as FDA commissioner Obama to nominate Dr Robert Califf as FDA commissioner

    That experience could serve the agency well as it faces the possibility of considerable changes to its activities under the House of Representatives' proposed 21st Century Cures Act, which, among other

  • Harnessing clinical data Harnessing clinical data

    The 21st Century Cures Act, which recently cleared one of its major hurdles by being approved by the House of Representatives in the US, includes a basket of initiatives aimed at

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics